Artis Ventures

ARTIS Ventures (AV) is a San Francisco-based venture capital firm founded in 2001 by Stuart Peterson. The firm coined and trademarked the term 'TechBio' to describe its focus on the convergence of technology and biology, investing in companies that apply data, software, AI, machine learning, and deep learning to transform human health and resilience. ARTIS primarily backs early-stage companies at the Seed and Series A stages, with some Series B participation. Its most recent vehicle, TechBio II, is the firm's fourth fund and closed in December 2023 at $200 million. Notable past investments include Palantir (IPO), YouTube (acquired by Google), and Stemcentrx (acquired by AbbVie). The firm runs a TechBio Fellows Program that embeds practicing MDs and PhD candidates within the investment team to support due diligence and portfolio companies.